Home
>
National Drug Code (NDC)
>
Ganciclovir
Ganciclovir - 55390-016-10 - (Ganciclovir sodium)
Drug Information of Ganciclovir
| Product NDC: | 55390-016 |
| Proprietary Name: | Ganciclovir |
| Non Proprietary Name: | Ganciclovir sodium |
| Active Ingredient(s): | 50 mg/mL & nbsp; Ganciclovir sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ganciclovir
| Product NDC: | 55390-016 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076222 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101230 |
Package Information of Ganciclovir
| Package NDC: | 55390-016-10 |
| Package Description: | 10 VIAL in 1 BOX (55390-016-10) > 10 mL in 1 VIAL |
NDC Information of Ganciclovir
| NDC Code | 55390-016-10 |
| Proprietary Name | Ganciclovir |
| Package Description | 10 VIAL in 1 BOX (55390-016-10) > 10 mL in 1 VIAL |
| Product NDC | 55390-016 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ganciclovir sodium |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20101230 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | GANCICLOVIR SODIUM |
| Strength Number | 50 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
